Stock Track | Treace Medical Concepts Plummets 5.21% as Analysts Maintain Neutral Ratings

Stock Track03-03

Treace Medical Concepts, Inc. (TMCI) saw its stock plummet 5.21% in the intraday trading session on Monday. The decline came as analysts from major financial institutions maintained their neutral ratings and price targets for the company.

Truist Securities reiterated its "Hold" rating on TMCI, while UBS adjusted its price target to $10 from $7.90 but kept a "Neutral" rating. According to analysts polled by FactSet, TMCI has an average rating of "Overweight" and a mean price target of $11.36.

The stock's plummet appears to be driven by the analysts' cautious outlook and lukewarm ratings, rather than any specific negative news or events related to the company. Investors may have reacted to the lack of bullish sentiment from analysts, leading to a sell-off in TMCI shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1195894772?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-03-04 04:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1195894772","market":"us","top_or_hot":-1,"title":"Stock Track | Treace Medical Concepts Plummets 5.21% as Analysts Maintain Neutral Ratings","media":"Stock Track","content":"<p>Treace Medical Concepts, Inc. (TMCI) saw its stock plummet 5.21% in the intraday trading session on Monday. The decline came as analysts from major financial institutions maintained their neutral ratings and price targets for the company.</p>\n\n<p>Truist Securities reiterated its \"Hold\" rating on TMCI, while UBS adjusted its price target to $10 from $7.90 but kept a \"Neutral\" rating. According to analysts polled by FactSet, TMCI has an average rating of \"Overweight\" and a mean price target of $11.36.</p>\n\n<p>The stock's plummet appears to be driven by the analysts' cautious outlook and lukewarm ratings, rather than any specific negative news or events related to the company. Investors may have reacted to the lack of bullish sentiment from analysts, leading to a sell-off in TMCI shares.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Treace Medical Concepts Plummets 5.21% as Analysts Maintain Neutral Ratings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Treace Medical Concepts Plummets 5.21% as Analysts Maintain Neutral Ratings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-03-04 04:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Treace Medical Concepts, Inc. (TMCI) saw its stock plummet 5.21% in the intraday trading session on Monday. The decline came as analysts from major financial institutions maintained their neutral ratings and price targets for the company.</p>\n\n<p>Truist Securities reiterated its \"Hold\" rating on TMCI, while UBS adjusted its price target to $10 from $7.90 but kept a \"Neutral\" rating. According to analysts polled by FactSet, TMCI has an average rating of \"Overweight\" and a mean price target of $11.36.</p>\n\n<p>The stock's plummet appears to be driven by the analysts' cautious outlook and lukewarm ratings, rather than any specific negative news or events related to the company. Investors may have reacted to the lack of bullish sentiment from analysts, leading to a sell-off in TMCI shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TMCI","symbol_name":"Treace Medical Concepts, Inc.","start_time":0,"source_url":"","article_id":"1195894772","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1195894772","pubTimestamp":1741032629,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Treace Medical Concepts, Inc.  saw its stock plummet 5.21% in the intraday trading session on Monday. The decline came as analysts from major financial institutions maintained their neutral ratings and price targets for the company.Truist Securities reiterated its \"Hold\" rating on TMCI, while UBS adjusted its price target to $10 from $7.90 but kept a \"Neutral\" rating. According to analysts polled by FactSet, TMCI has an average rating of \"Overweight\" and a mean price target of $11.36.The stock's","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TMCI":"Treace Medical Concepts, Inc."},"translate_title":"分析师维持中性评级，股票赛道Treace Medical Concepts暴跌5.21%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TMCI":1},"content_text":"Treace Medical Concepts, Inc. (TMCI) saw its stock plummet 5.21% in the intraday trading session on Monday. The decline came as analysts from major financial institutions maintained their neutral ratings and price targets for the company.\nTruist Securities reiterated its \"Hold\" rating on TMCI, while UBS adjusted its price target to $10 from $7.90 but kept a \"Neutral\" rating. According to analysts polled by FactSet, TMCI has an average rating of \"Overweight\" and a mean price target of $11.36.\nThe stock's plummet appears to be driven by the analysts' cautious outlook and lukewarm ratings, rather than any specific negative news or events related to the company. Investors may have reacted to the lack of bullish sentiment from analysts, leading to a sell-off in TMCI shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1195894772"}